If you need more lookups,
subscriptions start at $34 USD/month.
Cheryl McAlpine Location
Oxford, GB
Cheryl McAlpine Work
2023 -now Head of Translational Science @
2020 -2023 Director, Translational Sciences @
2014 -2020 Biomarker Group Leader, Translational Medicine @
2012 -2014 Development and Validation Team Leader @
2011 -2011 Pharmacology Team Leader and Principal Scientist @ Astellas Pharma US (Prosidion)
2009 -2010 Senior scientist and Team Leader @
2007 -2009 Senior scientist and Team Leader @
2001 -2007 Senior scientist and Team Leader @
2000 -2001 Postdoctoral Research @
1998 -2000 Postdoctoral Research @
Cheryl McAlpine Education
The University of Glasgow
PhD, Cardiovascular physiology/pharmacology
1994-1997
The University of Glasgow
BSc(Hons) First, Physiology
1990-1994
Cheryl McAlpine Skills
Pre-clinical safety studies
Assay Development
Pre-clinical R&D process
R&D
Scientific writing
PRINCE2 practitioner accreditation
Expertise in various drug target classes
Technical expertise in wide-range of in vitro pharmacological techniques
Clinical Development
Engaging project leader
Drug Discovery
In Vitro
Assay development and optimisation
Pharmacology
DMPK
Cross-functional Team Leadership
Lead finding and optimisation activities
strong interpersonal and communication skills
Molecular Biology
Cheryl McAlpine Summary
Cheryl McAlpine, based in Oxford, GB, is currently a Head of Translational Science at Grey Wolf Therapeutics. Cheryl McAlpine brings experience from previous roles at Adaptimmune, Immunocore, Merck Millipore and Astellas Pharma US (Prosidion). Cheryl McAlpine holds a 1994 - 1997 PhD, Cardiovascular physiology/pharmacology @ The University of Glasgow. With a robust skill set that includes Pre-clinical safety studies, Assay Development, Pre-clinical R&D process, R&D, Scientific writing and more. Cheryl McAlpine has 2 emails on RocketReach.
Looking for a different Cheryl McAlpine?
Find contact details for 700 million professionals.